About 625 results

ALLMedicine™ Blastomycosis Center

Research & Reviews  178 results

Closing the Brief Case: "Great Pretender"-Disseminated Blastomycosis in Western North C...
Journal of Clinical Microbiology; Kim MK, Smedberg JR et. al.

Nov 19th, 2021 - Closing the Brief Case: "Great Pretender"-Disseminated Blastomycosis in Western North Carolina.|2021|Kim MK,Smedberg JR,Boyce RM,Miller MB,|

The Brief Case: "Great Pretender"-Disseminated Blastomycosis in Western North Carolina.
Journal of Clinical Microbiology; Kim MK, Smedberg JR et. al.

Nov 19th, 2021 - The Brief Case: "Great Pretender"-Disseminated Blastomycosis in Western North Carolina.|2021|Kim MK,Smedberg JR,Boyce RM,Miller MB,|

Exclusively Tracheobronchial Paracoccidioidomycosis: A Rare Presentation.
Chest Corrêa LF, Fritscher CC et. al.

Nov 9th, 2021 - Paracoccidioidomycosis (PCM), or blastomycosis in South America, is a systemic granulomatous mycosis related to activities associated with soil management, especially agriculture. PCM restricted to tracheobronchial tree region has not yet been rep...

Disseminated blastomycosis in a patient with polycythemia vera on ruxolitinib.
BMJ Case Reports; Zeitler K, Jariwala R et. al.

Nov 3rd, 2021 - Ruxolitinib (RUX) is a kinase inhibitor used in the treatment of various medical conditions and its mechanism of action involves suppression of the immune system. While beneficial in treatment of polycythemia vera, myelofibrosis and other indicati...

Changing Patterns of Disease Severity in Blastomyces dermatitidis Infection, Quebec, Ca...
Emerging Infectious Diseases; Carignan A, Boudhrioua C et. al.

Oct 22nd, 2021 - This retrospective multicenter cohort study assessed temporal changes in the severity and mortality rate of blastomycosis in Quebec, Canada, and identified risk factors for death in patients with blastomycosis in 1988-2016. The primary outcome was...

see more →

Guidelines  1 results

Clinical practice guidelines for the management of blastomycosis: 2008 update by the In...
Clinical Infectious Diseases : an Official Publication Of... Chapman SW, Dismukes WE et. al.

May 9th, 2008 - Evidence-based guidelines for the management of patients with blastomycosis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous management guidelines published in the April ...

see more →

Drugs  48 results see all →

Clinicaltrials.gov  2 results

Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis

Jun 9th, 2006 - PROTOCOL OUTLINE: This is a study to estimate the optimal dose of oral itraconazole. Patients are treated at 1 of 3 doses of itraconazole; the starting dose for each patient is determined at entry. Therapy is administered daily for 3-6 months. Pat...

A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients...

Jun 24th, 2005 - Patients are randomized to receive IV itraconazole for 2 days, then either itraconazole daily for 5 days or amphotericin B daily for 7 days. IV treatment is followed by consolidation with oral itraconazole for up to 1 year.

see more →

News  21 results

Expanding Verrucous Plaque on the Face
Alyssa Miceli, DO, Ann Church, MD et. al.

Jan 7th, 2021 - The Diagnosis: Blastomycosis Histopathologic examination of 3 punch biopsies from the left side of the upper lip showed pseudoepitheliomatous hyperplasia with intraepidermal microabscesses and dermal suppurative granulomatous inflammation (Figure.

North American Blastomycosis in an Immunocompromised Patient

Dec 26th, 2019 - Punch biopsy from the upper back revealed a mixed acute and granulomatous infiltrate with numerous yeast forms (Figure 4A) that were highlighted by Grocott-Gomori methenamine-silver (Figure 4B) and periodic acid–Schiff (Figure 4C) stains. Figure 4.

North American Blastomycosis in an Immunocompromised Patient
Mayha Patel, DO, Jeffrey K. Lander, MD, PhD

Dec 26th, 2019 - Blastomycosis is a systemic fungal infection that is endemic in the South Central, Midwest, and southeastern regions of the United States, as well as in provinces of Canada bordering the Great Lakes. After inhalation of Blastomyces dermatitidis sp.

Pediatric Primary Cutaneous Blastomycosis Clinically Responsive to Itraconazole
Isabelle M. Sanchez, MPH, Lorelei E. DiTommaso, MD, MPH et. al.

Nov 1st, 2018 - Blastomycosis is a polymorphic disease caused by the thermally dimorphic fungus Blastomyces dermatitidis, which is naturally occurring worldwide but particularly prominent in the Great Lakes, Mississippi, and Ohio River areas of the United States.

Localized Pemphigus Foliaceus
Ashley Walker, DO, Tracy Favreau, DO

Jan 26th, 2017 - To the Editor: Pemphigus foliaceus is a rare autoimmune blistering disorder that typically presents with crusted scaly erosions in a seborrheic distribution. We describe a case of pemphigus foliaceus localized to the right cheek of 10 years’ durat.

see more →